Clinical Trial Update: OZ439 PhIIa Study in Plasmodium Falciparum: Extended Observation [Phase 2]

View source ↗

Summary

Phase 2 trial OZ439 for Plasmodium falciparum malaria completed with extended observation. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• OZ439

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2017-02-10